Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study
- 1 August 2007
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal Of Hypertension
- Vol. 25 (8), 1671-1677
- https://doi.org/10.1097/hjh.0b013e3281afa09e
Abstract
Because high circulating plasma leptin is associated with many features of the metabolic syndrome (MS), such as abdominal obesity, insulin resistance and high blood pressure (BP), we analysed the ability of plasma leptin concentration to predict the risk of developing MS in a prospective investigation of adult male participants of the Olivetti Heart Study (OHS). Three hundred and sixty out of 907 men participating in the 1994-95 and 2002-04 OHS examinations (mean age at baseline 50.4 years, range 25-73 years) were free of MS at first visit according to NCEP-ATP III criteria (modified for the lack of high-density lipoprotein cholesterol measurement at baseline). During an average follow-up period of 8 years, there were 52 incident cases of MS (14.5%) due, in particular, to a rise in the prevalence of high BP (+42.4%), abdominal obesity (+16.4%) and impaired fasting glucose (IFG, +6.1%). In multivariate analyses, a one standard deviation difference in baseline plasma leptin concentration was associated with a 1.58-fold greater risk of developing MS (95% confidence interval = 1.10-2.30, P = 0.016) accounting for age, waist circumference, homeostatic assessment model index, smoking, alcohol consumption and physical activity. In particular, plasma leptin was positively associated with the risk of developing high BP (0.006) and IFG (0.014), after adjustment for confounders. In this sample of an adult male population free of MS at baseline, circulating plasma leptin was a significant predictor of the risk of MS and, in particular, of its high BP and IFG components, independently of potential confounders.Keywords
This publication has 36 references indexed in Scilit:
- Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal functionAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescentsInternational Journal of Obesity, 2004
- Chronic leptin treatment enhances insulin-stimulated glucose disposal in skeletal muscle of high-fat fed rodentsLife Sciences, 2004
- Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat massActa Diabetologica, 2002
- Leptin and Metabolic Syndrome in Obese and Non-Obese ChildrenHormone and Metabolic Research, 2002
- Leptin and other components of the Metabolic Syndrome in Mauritius—a factor analysisInternational Journal of Obesity, 2001
- Pathophysiological role of leptin in obesity-related hypertensionJCI Insight, 2000
- Comment on the provisional report from the WHO consultationDiabetic Medicine, 1999
- Leptin inhibits insulin-stimulated incorporation of glucose into lipids and stimulates glucose decarboxylation in isolated rat adipocytesJournal of Endocrinology, 1998
- Is there a relationship between leptin and insulin sensitivity independent of obesity?A population-based study in the Indian Ocean nation of MauritiusInternational Journal of Obesity, 1998